Burning Rock Biotech earnings were -$10.1M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest BNR earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.7M, up 6.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, BNR reported annual earnings of -$7.9M, with -83.3% growth. The next BNR earnings date is Nov 19, 2026.
Burning Rock Biotech Earnings Reports & History FAQ
What were Burning Rock Biotech's earnings last quarter?
On BNR's earnings call on Sep 14, 2026, Burning Rock Biotech (NASDAQ: BNR) reported Q2 2026 earnings per share (EPS) of -$0.25, up 98.41% year over year. Total BNR earnings for the quarter were -$2.71 million. In the same quarter last year, Burning Rock Biotech's earnings per share (EPS) was -$0.13.
The next BNR earnings call is Nov 19, 2026. Add BNR to your watchlist to be reminded of Burning Rock Biotech's next earnings date.
What was BNR's earnings growth in the past year?
As of Burning Rock Biotech's earnings date in Sep 14, 2026, Burning Rock Biotech's earnings has grown year over year. BNR earnings in the past year totalled -$10.14 million.
Is Burning Rock Biotech profitable or losing money?
As of the last Burning Rock Biotech earnings report, Burning Rock Biotech is currently losing money. Burning Rock Biotech's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$10.01 million, a 48.85% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.